Tech Company Financing Transactions

Braeburn Pharmaceuticals Funding Round

Braeburn Pharmaceuticals, operating out of Princeton, raised $110 million from Wellington Management Company, Apple Tree Partners and Avista.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Braeburn will use the proceeds to continue to advance the FDA approval process, and commercialize CAM2038, an investigational buprenorphine weekly and monthly depot injection for the treatment of adults with OUD.

Company Information

Company Status
Private & Independent
Mailing Address
47 Hulfish St. 441
Princeton, NJ 08542
Email Address
Braeburn Pharmaceuticals is developing long-acting medicines for treating opioid addiction. Opioid addiction, also known as opioid use disorder (OUD) is a medical condition requiring medical treatment.
Braeburn Pharmaceuticals LinkedIn Company Profile
Social Media
Braeburn Pharmaceuticals Company Twitter Account
Company News
Braeburn Pharmaceuticals News
Braeburn Pharmaceuticals on Facebook
Braeburn Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Derkacz
  Michael Derkacz LinkedIn Profile  Michael Derkacz Twitter Account  Michael Derkacz News  Michael Derkacz on Facebook
Chief Financial Officer
David McIntyre
  David  McIntyre LinkedIn Profile  David  McIntyre Twitter Account  David  McIntyre News  David  McIntyre on Facebook
Chief Scientific Officer
Sonnie Kim
  Sonnie Kim LinkedIn Profile  Sonnie Kim Twitter Account  Sonnie Kim News  Sonnie Kim on Facebook
Vice President
Nancy Leone
  Nancy Leone LinkedIn Profile  Nancy Leone Twitter Account  Nancy Leone News  Nancy Leone on Facebook
VP - General Counsel
Paul Varki
  Paul Varki LinkedIn Profile  Paul Varki Twitter Account  Paul Varki News  Paul Varki on Facebook
VP - Regulatory Affairs
Ted Buckley
  Ted Buckley LinkedIn Profile  Ted Buckley Twitter Account  Ted Buckley News  Ted Buckley on Facebook
VP - Regulatory Affairs
Susan Franks
  Susan Franks LinkedIn Profile  Susan Franks Twitter Account  Susan Franks News  Susan Franks on Facebook



Browse more venture capital transactions:

Prev: 1/12/2018: Clevest venture capital transaction
Next: 1/12/2018: Anthera Pharmaceuticals venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary